# A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

> **NCT00005663** · PHASE3 · UNKNOWN · sponsor: **Glaxo Wellcome**

## Conditions studied

- Herpes Simplex
- HIV Infections
- Herpes Genitalis

## Interventions

- **DRUG:** Valacyclovir hydrochloride

## Key facts

- **NCT ID:** NCT00005663
- **Lead sponsor:** Glaxo Wellcome
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005663, "A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00005663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*